Liu Jun, Zheng Huimin, Ding Yangyang, Li Manman, Li Jingrong, Guo Jiaojiao, Hu Linhui, Pu Lianfang, Xiong Shudao
Department of Hematology/Hematological Lab.
Department of Emergency, The Second Hospital of Anhui Medical University, Hefei, Anhui.
Medicine (Baltimore). 2019 May;98(18):e15519. doi: 10.1097/MD.0000000000015519.
Krüppel-like factor 8 (KLF8), a transcription factor, belongs to the KLF8 family. Currently, studies have shown that KLF8 is highly expressed in some tumors. However, the prognostic value and metastasis of KLF8 in cancers remain unclear. For the first time, we conducted meta-analysis to explore the relationship between KLF8 expression with prognosis and metastasis in various carcinomas patients.
Web of Science, PubMed, Embase, and Cochrane Library were systematically searched for eligible articles. Pooled hazard ratios (HRs) and their 95% confidence intervals (95% CIs) were calculated to evaluate the prognostic value and metastasis of KLF8 expression in human cancer patients.
The result revealed that highly expression level of KLF8 was significantly associated with poor overall survival (OS) (HR = 1.56, 95% CI: 1.26-1.87). Meanwhile, this significant correlation was also observed in subgroup analysis stratified by cancer types, source of HR, sample size, follow-up (months). In addition, highly expression of KLF8 was also closely associated with metastasis (HR = 1.37, 95% CI: 0.57-2.17) and tumor node metastasis stage (HR = 1.58, 95% CI: 0.90-2.25) in carcinomas.
In summary, our meta-analysis indicates that overexpression of KLF8 may be associated with poor prognosis and higher incidence of metastasis in various carcinomas, and KLF8 may be used as a prognostic and metastatic indicator in human cancers.
Krüppel样因子8(KLF8)是一种转录因子,属于KLF8家族。目前,研究表明KLF8在某些肿瘤中高表达。然而,KLF8在癌症中的预后价值和转移情况仍不清楚。我们首次进行荟萃分析,以探讨KLF8表达与各类癌症患者预后和转移之间的关系。
系统检索Web of Science、PubMed、Embase和Cochrane图书馆,查找符合条件的文章。计算合并风险比(HRs)及其95%置信区间(95% CIs),以评估KLF8表达在人类癌症患者中的预后价值和转移情况。
结果显示,KLF8的高表达水平与总体生存率(OS)差显著相关(HR = 1.56,95% CI:1.26 - 1.87)。同时,在按癌症类型、HR来源、样本量、随访时间(月)分层的亚组分析中也观察到这种显著相关性。此外,KLF8的高表达在癌症中也与转移(HR = 1.37,95% CI:0.57 - 2.17)和肿瘤淋巴结转移分期(HR = 1.58,95% CI:0.90 - 2.25)密切相关。
总之,我们的荟萃分析表明,KLF8的过表达可能与各类癌症的不良预后和更高的转移发生率相关,并且KLF8可能作为人类癌症的预后和转移指标。